JPS63123387A - Production of gamma-halo-beta-hydroxybutyric ester - Google Patents
Production of gamma-halo-beta-hydroxybutyric esterInfo
- Publication number
- JPS63123387A JPS63123387A JP26867886A JP26867886A JPS63123387A JP S63123387 A JPS63123387 A JP S63123387A JP 26867886 A JP26867886 A JP 26867886A JP 26867886 A JP26867886 A JP 26867886A JP S63123387 A JPS63123387 A JP S63123387A
- Authority
- JP
- Japan
- Prior art keywords
- gamma
- cell
- ester
- halo
- culture solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 150000002148 esters Chemical class 0.000 title abstract description 16
- 239000000126 substance Substances 0.000 claims abstract description 5
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 abstract description 16
- 239000000243 solution Substances 0.000 abstract description 12
- 239000002609 medium Substances 0.000 abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 4
- 241000186321 Cellulomonas Species 0.000 abstract description 4
- 239000012736 aqueous medium Substances 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 229910052736 halogen Inorganic materials 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 2
- 125000000217 alkyl group Chemical group 0.000 abstract description 2
- 125000003118 aryl group Chemical group 0.000 abstract description 2
- 239000007853 buffer solution Substances 0.000 abstract description 2
- 229910052799 carbon Inorganic materials 0.000 abstract description 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000000050 nutritive effect Effects 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 18
- 239000002253 acid Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- OHLRLMWUFVDREV-UHFFFAOYSA-N ethyl 4-chloro-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)CCl OHLRLMWUFVDREV-UHFFFAOYSA-N 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000187844 Actinoplanes Species 0.000 description 3
- 241000589158 Agrobacterium Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000120652 Cellulomonas sp. Species 0.000 description 3
- 241001467578 Microbacterium Species 0.000 description 3
- 241000187654 Nocardia Species 0.000 description 3
- 241000187264 Planomonospora Species 0.000 description 3
- 241000589634 Xanthomonas Species 0.000 description 3
- 241000607734 Yersinia <bacteria> Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- -1 hydroxybutyrate ester Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- 241000186063 Arthrobacter Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000186146 Brevibacterium Species 0.000 description 2
- 241001491638 Corallina Species 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000588914 Enterobacter Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 241001637564 Kurtia Species 0.000 description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 241000589323 Methylobacterium Species 0.000 description 2
- 241000191938 Micrococcus luteus Species 0.000 description 2
- 241000187708 Micromonospora Species 0.000 description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 2
- 101100505672 Podospora anserina grisea gene Proteins 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000187123 Streptomyces vinaceus Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 241000203775 Thermoactinomyces Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229960003104 ornithine Drugs 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- AWFYPPSBLUWMFQ-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=C2 AWFYPPSBLUWMFQ-UHFFFAOYSA-N 0.000 description 1
- LXVSANCQXSSLPA-UHFFFAOYSA-M 2-ethyl-2-hydroxybutanoate Chemical compound CCC(O)(CC)C([O-])=O LXVSANCQXSSLPA-UHFFFAOYSA-M 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 241001291511 Actinoplanes capillaceus Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- 241000588813 Alcaligenes faecalis Species 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 241000186145 Corynebacterium ammoniagenes Species 0.000 description 1
- 241000186226 Corynebacterium glutamicum Species 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 241000186809 Kurthia Species 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241000186714 Lactobacillus amylophilus Species 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000589325 Methylobacillus Species 0.000 description 1
- 241001331072 Microbispora rosea subsp. aerata Species 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940005347 alcaligenes faecalis Drugs 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-VAYJURFESA-N aldehydo-L-arabinose Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-VAYJURFESA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000000963 caseinolytic effect Effects 0.000 description 1
- 241000186254 coryneform bacterium Species 0.000 description 1
- 235000021403 cultural food Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 1
- WASQWSOJHCZDFK-UHFFFAOYSA-N diketene Chemical compound C=C1CC(=O)O1 WASQWSOJHCZDFK-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- HOVAGTYPODGVJG-ZFYZTMLRSA-N methyl alpha-D-glucopyranoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-ZFYZTMLRSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000012771 pancakes Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はγ−ハロアセト酢酸エステルにバクテリア七作
用させて、γ−ハロ−β−ヒドロキシ酪酸エヌテルを製
造する方法に関する。γ−ハロ−β−ヒドロキシ酪飲エ
ステルHLIJルニチン等の医薬合成原料として有用で
ある。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a method for producing γ-halo-β-hydroxybutyric acid ester by reacting γ-haloacetoacetate with bacteria. It is useful as a raw material for pharmaceutical synthesis such as γ-halo-β-hydroxybutyric ester HLIJ lunitin.
〔従来の技術及び発明が解決しようとする問題点〕γ−
・・・アセト昨敵−ダル會化学的に還元して対応するγ
−ハロ−β−ヒドロキシ酪酸エステルを製造する揚台、
副反応が起こりやすく、目的物の収率が低いという欠点
がある。そごでこ几らt解決するために、L−β−ヒド
ロキシアシルCOAデヒドロrナーゼを産生ずる微生物
の発酵酵素作用を利用する方法(%開昭59−1)80
93号公報)が提案された。しかし、報告されている微
生物は、酵母、カビであり、史に、変異等の+段により
改良會加えるにあたって頁甲」なバクテリア?I−利用
する方法の確立が求められている。[Problems to be solved by conventional technology and invention] γ-
... Aceto's previous enemy - γ corresponding to dal by reducing it chemically
- a lifting platform for producing halo-β-hydroxybutyric acid ester;
The disadvantage is that side reactions are likely to occur and the yield of the target product is low. In order to solve the problem, a method using the fermentation enzyme action of microorganisms that produce L-β-hydroxyacyl COA dehydrogenase (% 1987-1) 80
Publication No. 93) was proposed. However, the microorganisms that have been reported are yeasts and molds, and in addition to the history of bacteria that have been improved through mutations and other steps, it is difficult to understand what bacteria is. I- There is a need to establish a method for utilizing it.
本発明は、γ−ハロアセト酢酸エステルケ対応するγ−
ハロ−β−ヒドロキシ酪酸エステルに変換するIj〔力
會有するバクテリアの培養液、菌体、又は菌体処理@t
γ−ハロアセト酢酸エステルに作用ざゼ、生成物上採取
することを特徴とするγ−ハロ−β−ヒドロキシ面酸エ
ステルのim法である。The present invention provides γ-haloacetoacetic esters and corresponding γ-
Converting to halo-β-hydroxybutyric acid ester
This is an im method for producing γ-halo-β-hydroxyface acid ester, which is characterized in that it acts on γ-haloacetoacetate and collects the product.
本発明で用いるr−ハロアセト酢酸エステルは、一般式
: R,−CH2Co −CE(2COOR2(式中R
1はハロゲンであり、
R2はアルキル基、フェニル基、アリ
ール基寺の任意のM機残基である)
で示される化合物である。The r-haloacetoacetate used in the present invention has the general formula: R, -CH2Co -CE(2COOR2 (in the formula R
1 is a halogen, and R2 is an optional M residue of an alkyl group, phenyl group, or aryl group.
本発明で用いるγ−ハロアセト酢酸エヌテルは、例えば
百機浴媒でハロゲンとジケテンを反応させることにより
得られるが、心壁ならγ−ハロアセト酢酸エステルから
通常のグリニヤール反応によっても製造することができ
る。The γ-haloacetoacetic acid ester used in the present invention can be obtained, for example, by reacting a halogen with a diketene in a bath medium, but the heart wall can also be produced from γ-haloacetoacetic acid ester by a conventional Grignard reaction.
本発明で用いるバクテリウムユ、γ−ハロアセト酢酸エ
ステルを対応するγ−ハロ−β−ヒドロキシ酪酸エステ
ルに変換する能力を儒するバクテリアであり、例えば、
オーレオバクテリウム(Aureobacterlum
) fiアルカリrネス(Alcaligenes
) 属アグロバクテリウム(Agrobacteriu
m ) Jf4アリ、xoバクター(Arthroba
cter )属アモルフオスボランイウム(Amo r
pho e po rangium)鵬
アムプラリエラ(Ampullariella ) 族
ブレビバクテリウム(Brevibacterium
)属パテh ス(Bacillus )属
コリネバクテリウム((:orynebacteriu
m ) P!4セルロモナス(Cellulomona
a ) 属エシェリキア(Escherichia )
属エンテロバクタ−(Knterobacter )
属7うMバクテリウム(FlaVOk)aiQ’lri
um ) FAハフニア(Hafinia ) )A
クルチア(Kurthia )属
ラクトバチルス(Lactobacillua)属ミク
ロコツカス(Micrococcue ) 754メタ
ノモナス(Methanomonas ) )94メチ
ロバシルス()4athylobacillus )属
ミクロビスポラ(Mlcrobispora ) Mミ
クロ七ノスホラ(Micromonospora )属
ノカルジア(Nocaraia )属
プロテウス(Proteua )属
シュードモナ、X (P8eu(LOmOnaa )
h4ベデオコツカス(Pediococcua ) Q
4プラノモノスポラ(Planomonospora
)属プロト七ナス(protomonaa )属ロドコ
ッカス(Rhodoccus )属セラチア(5err
atia )属
ストレプトマイセス(Streptomyces )属
す−モアクチノミセ;x、 (Thermoactin
omycea )属
キサントモナスCXanthOmOnaa ) 、1エ
ルシニア(Yersinia )属
に属するバクテリアである。更に具体例tあげると、
オーレオバクテリウム テレデンスエFO12961(
Aureobacterium terragens
)アルカリゲネス ファエカリス エF′012669
(AlcaligeHes faacalis )ア
グロバクテリウム ラジオバクター エAM 152
6(Agrobacterium radiobact
er )アリスロバクター シンプレックス エFO
12069(Arthrobacter aimpl
ec )アモルフオスポランギウム アラランティカラ
ー JCM 3[]38(AmorphospOran
gium auranticolor )アムプラリ
エラ キリニブリカ JCM 3329(Ampul
lariella cylindrica )ブレビバ
クテリウム アンモニアゲネス エFO12071(
Brevibacterium ammoniagen
ee )バチルス ズプチルス エF0 3037(
Bacillus 5ubtilia )コリネバ
クテリウム ダルタミクム 4534 ATCC13
032(Corynebacterium gluta
micum )セルロモナス エスピー AKU 67
2(Cellulomonas sp、 )エシェリ
キア コリ K12 工F′03208(Ksher
ichia coli )エンテロバクタ−アエロデ
ネス JCM 1235(1nterobacter
aerogenes )フラボバクテリウム ニス
テロアロマティクム エFO37b1(1avobac
teriu+n eat、eroaromaticum
)ハフニア アルベイ IFO3731
(Hafin:La alvei )クルチア ゾフ
イ エF0 12083(Kurthia zopfi
ン
ラクトバチルス アミロフィルス JCM 1)24
(Lactobaci:Llus amylophil
us )ミクロコツカス ルテウス エFO1270
8(Micrococcus 1uteua )メタ
ノモナス メチロボラ JCM 2848(Meth
anomOnas methylovora )メテ
ロバシルス グリコゲネス JCM 2850(M8t
h71ObaC1llu8 g17cOgene8 )
ミクロビスポラ アエラタ JCM 3076(Mi
crobispora aerata )ミクロモノ
スポラ グリセア JCM 3182(Microm
onos・pora grisea )ノカルジ
ア コラリナ エAM 12121(Nocardi
a corallina )プロテウス ミラビルス
エ1’0 3849(Protθus mirab
illg )シュードモナス クルシビアエ エyo
12047(Pseuaomonaa cruciv
iae )ペデオコッカス ベントサセウス JCM
2023(peaiococcus pentos
aceus )プラノモノスポラ ベネズエレシェンシ
ス JCM 3167(PlanomOnoapora
venezuelensis )プロトモナス
エクストロクエンス JCM 281)(Protom
onas extroquens )ロドコッカス
コラリナ JCM3199(Rhodococua
corallina )セラチア マルセシェンス エ
AM 1)05(Eleratia marcesc
ens )ストレプトマイセス アラビクス JcM4
161(streptomyces arab
icus )サーモアクチノミセス サラカリ :r
c>i 3137(Thermoactinomyc
es aacchari )キサントモナス マルト
マイリア 、TCM 1975(Xanthomona
s maltophilia )エルシニア ルケリ
JCM 2429(Yersinia ruk
eri )等である。こnらの菌株は財団法人発酵研死
プ(工FO)、東京大学応用微生物研究所(IAM )
、または理化学研究所微生物系統保存yi1)設(JC
M)ATCC等に、それぞれの番号で保¥tされており
、必要に応じて容易に入手できる菌株である◎このうち
、セルロモナスニスt−AxU672iは本発明者らが
見いだした菌株であり、1莱技術院微生物工業技術研究
所に寄託番号9026番で寄託されている。菌学的性5
!i’に次に示す。The bacterium used in the present invention is a bacterium that has the ability to convert γ-haloacetoacetate to the corresponding γ-halo-β-hydroxybutyrate, such as Aureobacterium.
) fi alkaline rness (Alcaligenes)
) Genus Agrobacterium (Agrobacterium)
m) Jf4 ant, xo bacter (Arthroba
cter ) genus Amorphosboranium (Amor
pho e po rangenium) Ampullariella family Brevibacterium
) Genus Bacillus h Genus Corynebacterium ((: orynebacterium
m) P! 4 Cellulomonas
a) Genus Escherichia
Genus Enterobacter
Genus 7 M Bacterium (FlaVOk) aiQ'lri
um ) FA Hafinia ) A Genus Kurtia Genus Lactobacillus Micrococcue 754 Methanomonas ) 94 Methylobacillus () 4 athylobacil Mlcrobispora (Mlcrobispora) Mlcrobispora (Micromonospora) Nocardia (Nocaraia) Genus Proteua Genus Pseudomona, X (P8eu (LOmOnaa)
h4 Pediococcua Q
4 Planomonospora (Planomonospora)
) Genus protomonaa Genus Rhodoccus Genus Serratia (5err
atia) belonging to the genus Streptomyces - Moactinomyce;
omycea), genus Xanthomonas (CXanthOmOnaa), 1 is a bacterium belonging to the genus Yersinia. To give a more specific example, Aureobacterium teledensae FO12961 (
Aureobacterium terragens
) Alcaligenes faecalis E F'012669
(AlcaligeHes faacalis) Agrobacterium radiobacter air AM 152
6 (Agrobacterium radiobacterium
er) Arylobacter simplex eFO
12069 (Arthrobacter aimpl
ec ) Amorphosporangium aranticolor JCM 3 [] 38 (Amorphosporangium
gium auranticolor) Ampurariella kiriniblica JCM 3329 (Ampul
lariella cylindrica) Brevibacterium ammoniagenes FO12071 (
Brevibacterium ammonium
ee) Bacillus subtilis E F0 3037 (
Bacillus 5ubtilia) Corynebacterium daltamicum 4534 ATCC13
032 (Corynebacterium gluta
micum) Cellulomonas sp. AKU 67
2 (Cellulomonas sp, ) Escherichia coli K12 Eng F'03208 (Ksher
ichia coli) Enterobacter aerodenes JCM 1235 (1nterobacter
aerogenes) Flavobacterium Nisteroaromaticum EFO37b1 (1avobac
teriu+n eat, eroaromaticum
) Hafin: La alvei IFO3731 (Hafin:La alvei) Kurtia zopfi F0 12083 (Kurthia zopfi
Lactobacillus Amylophilus JCM 1) 24
(Lactobacillus: Llus amylophil
us ) Micrococcus luteus eFO1270
8 (Micrococcus 1uteua) Methanomonas Methylobora JCM 2848 (Meth
anomOnas methylovora) Meterobacillus glycogenes JCM 2850 (M8t
h71ObaC1llu8 g17cOgene8)
Microbispora aerata JCM 3076 (Mi
crobispora aerata) Micromonospora grisea JCM 3182 (Micro
onos・pora grisea) Nocardia coralinae AM 12121 (Nocardia
a corallina) Proteus mirabillus E1'0 3849 (Protθus mirab
illg) Pseudomonas crucibiae ayo
12047 (Pseuaomonaa cruciv
iae ) Pedeococcus bentosaceus JCM
2023 (peaiococcus pentos
aceus) Planomonospora venezueleschensis JCM 3167 (PlanomOnoapora
venezuelensis) Protomonas
Extroquence JCM 281) (Protom
onas extroquens) Rhodococcus
Coralina JCM3199 (Rhodococua
corallina ) Serratia marcescens AM 1) 05 (Eleratia marcesc
ens ) Streptomyces arabicus JcM4
161 (streptomyces arab
icus) Thermoactinomyces Sarakari :r
c>i 3137 (Thermoactinomyc
es aacchari) Xanthomonas maltomilia, TCM 1975 (Xanthomona
s maltophilia ) Yersinia rukeri JCM 2429 ( Yersinia ruk
eri) etc. These strains were collected by Hakko Research Foundation (Engineering FO) and Institute of Applied Microbiology (IAM), the University of Tokyo.
, or the RIKEN Microbial System Conservation Yi1) establishment (JC
M) It is a strain that is maintained by ATCC etc. under its respective number and can be easily obtained as needed ◎Among these, Cellulomonasnis t-AxU672i is a strain discovered by the present inventors, and 1. It has been deposited with the Institute of Microbial Technology, Agency of Technology under deposit number 9026. Mycological 5
! i' is shown below.
1、形態
(1)細胞の形及び太きg:
Qld culture :球菌、1).5〜0.6
μff1Fresh culture :不定形、桿菌
、径0.5〜0.7μm、長さ〉2.0μm
(21多形性の刊無二M
(3)運動性の有無二頁
(4) 鞭毛の有無 :頁
(5) 胞子の有無 :無
(6) ダラム染色性:陽性
2、各培地での生育状態
(1)肉汁寒天平板培養
コロニーの色 :黄色(2日間培養〕
コロニーの形状二円形、平滑
コロニーの隆起:中央凸状
コロニーの周縁:全線
(2) 肉汁液体培養
凹環、やや沈殿■
(3) 肉汁ゼラチン穿刺培養:液化する(4)
リドマスミルク:酸を生成する6、生理学的性質
(1)硝酸塩の還元 :■
(2+MRテスト :陰性
(31VPテスト :陰性
(4)インドールの生成 :陰性
(5; 硫化水素の生成 :陰性
(6) デンプンの加水分所:陽性
(7) クエン酸の利用 :陰性
(8)色素の生成 :無
(9) ウレアーゼ :陰性
a(2)オキシダーゼ :陰性
αD カタラーゼ :陽性
α21 酸系に対する態反 :好気性αj 生育の範
囲
温度 37S42℃
PH6,0〜7.5
Q41OFテスト :発酵
(151セルロースに対する作用:陰性(16)糖類か
らの酸及びガスの生成の■無糖 類
酸 ガス
■ L−アラビノース 十 −■ Arb
utln + −■ セルロモ
ナス 十 −■ デキストリン
+ −■ D−フラクトース +
−■ D−ガラクトース 十 −■ D
−グルコース 十 −■ グリコーゲ
ン 十 −■ マルトース
+ −〇 デンプン 士
−■ ショ糖 十
−@ ) L/ハ0−ス(treha108リ
+ −Oキシロース 十 −
■ グリセロール − −〇 イヌ
リン −−
@lLa −−Oマニトール
− −Oマンノース
− −◎ α−メチルグルコシド −
−(α−meth)rlglucosiae )Oラ
フィノース − −[相] ラムノー
ス −−〇 ンルビトール
−−
〇 ンルボース − −任71
DNA分解性:陽性
b カゼイン分解性
アミノペプチターゼ活性:陰性
σ壮 耐塩性: NIL(15気1で生育する■; 細
胞壁のアミノ酸:オルニチン
c!1)細胞分裂:屈曲
+221 DNA (D GCt* : 74.7
%(ハ)スキムミルク甲における熱処理:66℃、60
分処理で生存
以上の菌学的性鴬により、本菌はコリネフォルムバクテ
リアに極し、山田らの方法(、r、 Gθn。1. Morphology (1) Cell shape and thickness: Qld culture: Coccus, 1). 5-0.6
μff1Fresh culture: Amorphous, rod, diameter 0.5-0.7 μm, length > 2.0 μm (21 Polymorphic publication M (3) Presence or absence of motility, page 2 (4) Presence or absence of flagella: page (5) Presence or absence of spores: None (6) Durham staining: Positive 2, Growth status on each medium (1) Color of broth cultured on broth agar plate Colony: Yellow (cultured for 2 days) Colony shape: dicircular, smooth colony Elevation: Periphery of central convex colony: Full line (2) Meat juice liquid culture concave ring, slightly precipitated ■ (3) Meat juice gelatin puncture culture: Liquefies (4)
Lidomus milk: produces acid 6, physiological properties (1) Reduction of nitrate: ■ (2+MR test: Negative (31VP test: Negative (4) Production of indole: Negative (5); Production of hydrogen sulfide: Negative (6) Starch Hydrolysis site: Positive (7) Utilization of citric acid: Negative (8) Pigment formation: None (9) Urease: Negative a (2) Oxidase: Negative αD Catalase: Positive α21 Attitude towards acid systems: Aerobic αj Growth range temperature 37S42℃ PH6.0-7.5 Q41OF test: Fermentation (151 Effect on cellulose: Negative (16) ■ Sugar-free of acid and gas production from sugars
Acid gas■ L-arabinose -■ Arb
utln + -■ Cellulomonas ten -■ Dextrin
+ -■ D-fructose +
−■ D-galactose 10 −■ D
−Glucose 10 −■ Glycogen 10 −■ Maltose
+ −〇 Starch
−■ Sucrose 10
-@) L/ha0-su(treha108li + -O xylose 10 - ■ Glycerol - -〇 Inulin -- @lLa --O Manitol
- -O Mannose
− −◎ α-Methylglucoside −
-(α-meth)rlglucosiae)O raffinose - - [phase] Rhamnose --〇 Lubitol
−− 〇 Nrubosu − −Rin71
DNA degradability: Positive b Caseinolytic aminopeptidase activity: Negative σ Salt tolerance: NIL (Grows at 15 Qi 1 ■; Cell wall amino acid: Ornithine c!1) Cell division: Bend + 221 DNA (D GCt*: 74.7
%(c) Heat treatment on skim milk instep: 66℃, 60
Due to the mycological properties of the bacteria, which were more than viable during the separation process, this bacterium was classified as a coryneform bacterium, and the method of Yamada et al.
ApploMlcroblol、、 1 8. 41
7 (1972))に基づいて検索すると
■ セルロース分解活性が欠損
■ 細胞分裂か屈曲型
■ 細胞壁のアミノ酸がオルニチン
■ ()C含量が71〜76係と範囲が狭く筒宮量
■ 広範囲の糖から発酵により鈑ケ作るという点から、
第4グループに鵬し、セルロモナスエスピーと、同定さ
れた。ApploMlcroblol, 18. 41
7 (1972)) ■ Cellulose decomposition activity is lacking ■ Cell division or bending type ■ Amino acid in the cell wall is ornithine ■ () C content is narrow in the range of 71 to 76 and the amount of cylindrical ■ A wide range of sugars From the point of making pancakes through fermentation,
The fourth group was identified as Cellulomonas sp.
上記のバクテリアは一般的性饗として自然あるいは人工
的+股により変異奮起し借るが、γ−ハロアセト酢酸エ
ステル會還元してγ−ハロ−β−ヒドロキシ酪酸エステ
ルに変換するもの丁べて本発明の製造法に利用し得る。The above-mentioned bacteria are generally mutated naturally or artificially, but all of the bacteria that reduce γ-haloacetoacetate and convert it to γ-halo-β-hydroxybutyrate are the ones of the present invention. Can be used in manufacturing methods.
本発明で用いるバクテリアは常法に従って培養すること
ができる。培養に用いられする培地はバクテリアの生育
に必要な炭素源、窒素源、無機P4IJ質等を含む通常
の培地である。更にビタミン、アミノ酸等の有機微量栄
養素を添加すると望ましい結果が得られる場合が多い。The bacteria used in the present invention can be cultured according to conventional methods. The medium used for culturing is a conventional medium containing carbon sources, nitrogen sources, inorganic P4IJ substances, etc. necessary for the growth of bacteria. Additionally, desirable results can often be obtained by adding organic micronutrients such as vitamins and amino acids.
培養は好気的条件下にpH3〜8、温良10〜40℃の
適当な範囲に制御しつつ1〜10日間培養を行う。反応
にあたっては、バクテリアの培養液、培養液から分離採
取した培養一体などいずれも使用できる。Im菌体処理
物として、凍結乾燥やアセトン乾燥などの方法で得た乾
燥1体、一体音磨砕あるいは自己消化、超音波処理など
の方法で得た国体破砕液のほか、γ−710アセト酢酸
エステルを対応するγ−ハロ−β−ヒドロキシ陥敞エス
テルに変換する酵素活性を刹する酵素タンパク区分、更
にはこれら菌体17cは一体処理物の同定化物、七の他
いずれも使用できる。The culture is carried out under aerobic conditions for 1 to 10 days while controlling the pH to 3 to 8 and the temperature to an appropriate range of 10 to 40°C. For the reaction, either a bacterial culture solution or a culture isolated from the culture solution can be used. Im bacterial cell processing products include one dried cell obtained by methods such as freeze-drying or acetone drying, Kokutai crushed liquid obtained by methods such as integral sonic grinding, autolysis, and ultrasonic treatment, as well as γ-710 acetoacetic acid. An enzyme protein class having the enzymatic activity of converting an ester into the corresponding γ-halo-β-hydroxy-enzymatic ester, and any identified product of the bacterial cells 17c or 7 can be used.
γ−ハロアセト酢酸エステルを対応するγ−ハロ−β−
ヒドロキシ酪酸エステルに変換する方法は、水性媒体中
にてγ−ハロアセト酢酸エステルと上記バクテリアの培
養奴、1体、一体処理物あるいはこれらを公知の方法で
固定化し友ものと接触さセれは艮い。γ-haloacetoacetate corresponding to γ-halo-β-
The method for converting to hydroxybutyrate ester involves culturing γ-haloacetoacetate and the above-mentioned bacteria in an aqueous medium, immobilizing them individually, treating them together, or immobilizing them by a known method and bringing them into contact with a friend. stomach.
かかる反応時の水性媒体としては、水、緩衝欣および含
水百機浴媒が使用できる。As the aqueous medium for such a reaction, water, a buffer solution, and a water-containing bath medium can be used.
上記バクテリアtγ−ハロアセト酢酸エステルに作用さ
ゼるには、通常、pH’に3〜8、反応温度上10〜6
0℃の範囲に制御しつつ行なう。In order to act on the bacterial tγ-haloacetoacetate, the pH is usually 3 to 8 and the reaction temperature is 10 to 6.
The temperature is controlled to be within the range of 0°C.
反応系に対してr−ハロアセト酢酸エステルはそのまま
、あるいは溶媒に俗解するか、あるいは分散させて添加
する。The r-haloacetoacetic acid ester is added to the reaction system as it is, in a solvent, or after being dispersed.
反応系のエステル@友は通T60.001〜50″M宜
呪の範囲が良い。かかるγ−ハロアセト酢酸エステルの
僑加は反応の任意の段階で可能であり、−括、連続、分
割のいずれの中段でも実施できる。The reaction system ester@tomo is preferably in the range of 60.001~50''M.The addition of such γ-haloacetoacetic ester is possible at any stage of the reaction; It can also be carried out in the middle stage.
反応時にグルコース等の糖類や、微生物の栄養素、界面
活性剤等を共存させて反応を行なうこともできる。反応
時間は、#度等条件により調整できるか、長くとも48
時間程技を行なえば、r−ハロアセト酢酸エステルは対
応するγ−ハロ−β−ヒドロキシ酪骸エステルに変挾さ
れる。The reaction can also be carried out in the presence of sugars such as glucose, nutrients for microorganisms, surfactants, and the like. The reaction time can be adjusted depending on conditions such as # degree, or at most 48
After a period of time, the r-haloacetoacetic ester is converted to the corresponding γ-halo-β-hydroxybutyric ester.
このようにして得られたγ−ハロ−β−ヒドロキシ酪酸
エステルケ培養液又は反応液より採取するには、1体又
は函体処理@七遠心分離や限外痣過等の常法に従って除
去し、エーテル、四塩化炭素、ベンゼン、酢酸エチル等
のM機泪媒を用いて′抽出する方法等の通常の方法を採
用することができる。To collect the thus obtained γ-halo-β-hydroxybutyric acid ester from the culture solution or reaction solution, remove one body or a box using conventional methods such as centrifugation or ultrafiltration. Conventional methods such as extraction using a medium such as ether, carbon tetrachloride, benzene, or ethyl acetate can be employed.
次に、実施例によって発明−〇方@を更に評しく説明す
る。Next, the invention-〇 method @ will be further described with reference to Examples.
実施例1
グルコース5に、社’L コーン・ステイープ・リカー
5重量くからなる培地(p[(6,5)5祷を試験管に
取り、表に示した微生物を接桓して28°Cで48時間
振とり培養を行つ文。Example 1 A medium (p[(6,5)) consisting of 5 parts glucose and 5 parts by weight of Company's L Corn Steep Liquor was placed in a test tube, the microorganisms shown in the table were inoculated, and the mixture was heated at 28°C. A statement of shaking culture for 48 hours.
この系にγ−クロロアセ)I!rl−酸メチル25μl
を督加し、さらに24時r=4伽とう培傭會続り°反応
を行なった。In this system, γ-chloroacetyl)I! 25 μl of methyl rl-acid
was applied, and the reaction was continued for 24 hours at r=4.
得られた反応液を遠心分離で除重M処理した後、反応h
2rnit酢叛エテル4 ut&で抽出し、ガスクロマ
トグラフィー(島g Gc −1,I APF、 P
凹G20MX1rn、150℃、N230m17 m1
n )で分析し友。粘果七表に示す。The resulting reaction solution was subjected to deweighting M treatment by centrifugation, and then the reaction h
Extracted with 2rnit acetate ether 4 ut and subjected to gas chromatography (Gc-1, I APF, P
Concave G20MX1rn, 150℃, N230m17 m1
n) to analyze it. Shown in Table 7.
実施例2
γ−クロロアセト酢酸エチルを基債に用いて実施例1と
同様に反応を行い、分析した。結果を表に示す。Example 2 A reaction was carried out and analyzed in the same manner as in Example 1 using ethyl γ-chloroacetoacetate as the base bond. The results are shown in the table.
以下余白
実施例6
グルコース5fKit%、コーン・ステイープリカー5
重食%からなる培地(pH6,5)51)Lt’t−試
験官に取り、セルロモナスエスピーAKU 672 (
倣工研菌寄第9026号)會接植して28℃で24時間
振とり培養を行ない種培養at得た。Below is the margin Example 6 Glucose 5fKit%, corn staple liquor 5
Medium (pH 6,5) consisting of 51) Lt't- tester and Cellulomonas sp. AKU 672 (
Seed culture at was obtained by inoculating the seedlings and culturing them with shaking at 28° C. for 24 hours.
次に上記と同一組成の培地1001)Ltを500祷容
坂ロフラスコに取り、糧培養液5祷?雄加して28℃で
振とう培養を行なった。Next, take 1001) Lt of culture medium with the same composition as above into a 500-liter flask, and add 500ml of food culture solution. Males were added and cultured with shaking at 28°C.
得られた培養液會遠心分離し、0.9%NaC1水で洗
浄し九のち、1(W/V)’36のグルコ−ステ含¥J
O,IMリン酸緩衝液(pi(6,0) 100WLt
に懸濁し、γ−クロロアセト酢酸エチル1−0.!i’
に?Fi加し、通気、振とうしながら18時間反反応性
なった。The resulting culture solution was centrifuged, washed with 0.9% NaCl water, and then diluted with 1 (W/V) '36 of glucose.
O,IM phosphate buffer (pi(6,0) 100WLt
Suspended in ethyl γ-chloroacetoacetate 1-0. ! i'
To? After adding Fi, the mixture became unreactive for 18 hours while being aerated and shaken.
得られた反芯液r遠lL?分離で除菌処理した後、酢%
xチル300mA(1(10rILtX3回)で抽出?
行なった。この酢酸エチル層に無水硫臣マグネシウムk
m加、脱水したのち、減圧−稲して0.989の油状生
成物を得九。このものt減圧蒸留して工R(島渾工R−
435)、NmR(日本電子PMX608工)、ガスク
ロマトグラフィー(島*GC−9APFS PE020
MX1m、150℃、N23 Q rnl / min
ンで確認したところ、γ−クロローβ−ヒドロキシ酪酸
エチルであることを確認し几。The obtained anti-core liquid r? After sterilization treatment by separation, vinegar%
Extract with x chill 300mA (1 (10rILt x 3 times)?
I did it. Anhydrous magnesium sulfate is added to this ethyl acetate layer.
After adding water and dehydrating, it was vacuum-dried to obtain an oily product with a weight of 0.989. This product is distilled under reduced pressure.
435), NmR (JEOL PMX608 Engineering), gas chromatography (Shima*GC-9APFS PE020
MX1m, 150℃, N23 Qrnl/min
When the sample was checked with a sample, it was confirmed that it was ethyl γ-chloroβ-hydroxybutyrate.
NMR
δ(CDC13中):δ(1)Pm )1.25(3H
,t)、2.60(2H,a)、3.35 (I H,
s 、 exthangeable 、 OH)3
−60 (2Ht d)、4−2 (2a、 q
)C
R−TC分)4.6
実施例4
ミクロコツカス ルテウス エFO12708’に実施
例6と同様にして培養と反応全行ない生成物r分離した
ところ0.85 gの油状生取物會得た。NMR δ (in CDC13): δ(1)Pm) 1.25 (3H
, t), 2.60 (2H, a), 3.35 (I H,
s, exchangeable, OH)3
-60 (2Ht d), 4-2 (2a, q
) CR-TC min) 4.6 Example 4 Micrococcus luteus e FO12708' was cultured and reacted in the same manner as in Example 6, and the product r was separated, yielding 0.85 g of an oily raw material.
さらに、実施例3と同様の方法で同定し友ところ、γ−
クロローβ−ヒドロキシ@酸エチルであることkr4認
した。Furthermore, γ-
kr4 was confirmed to be chloroβ-hydroxy@ethyl acid.
実施例5
γ−クロロアセト酢絃オクチル’kM’Thに用いて、
実施例3と同様にして反応7行ない、ガスクロマトグラ
フィーC島?4tGC−9APF、oV−IXI風、1
25°Cs N230 ’ /分ン、IR(島津工R−
455)、NMR(JKOLGX−270)T確認り。Example 5 Using γ-chloroacetoacetate octyl 'kM'Th,
Seven reactions were carried out in the same manner as in Example 3, and gas chromatography was carried out. 4tGC-9APF, oV-IXI style, 1
25°Cs N230'/min, IR (Shimadzu R-
455), NMR (JKOLGX-270) T confirmed.
たところ、γ−クロローβ−ヒドロキシ@酸オクチルで
あるごとr確認した。1−反応収率は50%であった。As a result, it was confirmed that it was octyl γ-chloroβ-hydroxy@acid. 1-Reaction yield was 50%.
尚、基餉は1−の10% Tween 80 (KA
O−ATLAS )で乳化して反応系に添加した。The basic ingredient is 10% Tween 80 (KA
(O-ATLAS) and added to the reaction system.
5ji!Th例6
実施例6と同様にして得fc湿菌体10gk20−の0
.1Mリン酸緩衝液(pH6,5)にけん〜し、氷水で
冷却しながら5分間の超音波処理會4回行い、遠心分離
で不?6?!lk除去することにより、粗酵索欣を得た
。5ji! Th Example 6 10 g of fc wet bacterial cells obtained in the same manner as in Example 6
.. Suspended in 1M phosphate buffer (pH 6.5), cooled with ice water, sonicated for 4 times for 5 minutes, and then centrifuged to remove any residue. 6? ! By removing lk, a crude fermentation compound was obtained.
この粗#累液101dに’NADPH(シグマ社)20
0■?加え、γ−クロロアセト酢岐エチル20即會4時
間で分添し、さらに4時間反応上行った後、実施例6と
同様にして反応液?分析したところ、γ−クロローβ−
ヒドロキシ酪酸エチルの収率は90%であった。'NADPH (Sigma) 20 to this crude #accumulated liquid 101d
0■? In addition, 20 ethyl γ-chloroacetoacetate was immediately added in portions over a period of 4 hours, and after further reaction for 4 hours, the reaction solution was added in the same manner as in Example 6. Analysis revealed that γ-chloroβ-
The yield of ethyl hydroxybutyrate was 90%.
実施例7
実施例6と同様にして培養し、得られた培養液にシュー
クロース10gkti加し、通気培養しなからγ−クロ
ロアセト酢酸エチル1 g’t8時間で分臨し、さらに
通気培養上8時間行い笑り例1と同様にして反応激音分
析したところγ−クロローβ−ヒドロキシ酪酸エチルの
収率は40呪であったO
〔発明の効果〕Example 7 Cultivation was carried out in the same manner as in Example 6, 10 gkti of sucrose was added to the resulting culture solution, and after aeration culture, 1 g of ethyl γ-chloroacetoacetate was dispensed every 8 hours. When the reaction noise was analyzed in the same manner as in Example 1, the yield of γ-chloroβ-ethyl butyrate was 40%. [Effects of the invention]
Claims (1)
−β−ヒドロキシ酪酸エステルに変換する能力を有する
バクテリアの培養液、菌体、又は菌体処理物をγ−ハロ
アセト酢酸エステルに作用させ、生成物を採取すること
を特徴とするγ−ハロ−β−ヒドロキシ酪酸エステルの
製造法。(1) Produced by reacting γ-haloacetoacetate with a culture solution, bacterial cells, or treated bacterial cells that have the ability to convert γ-haloacetoacetate into the corresponding γ-halo-β-hydroxybutyrate. 1. A method for producing γ-halo-β-hydroxybutyric acid ester, which comprises collecting a substance.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26867886A JPS63123387A (en) | 1986-11-13 | 1986-11-13 | Production of gamma-halo-beta-hydroxybutyric ester |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26867886A JPS63123387A (en) | 1986-11-13 | 1986-11-13 | Production of gamma-halo-beta-hydroxybutyric ester |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63123387A true JPS63123387A (en) | 1988-05-27 |
Family
ID=17461870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP26867886A Pending JPS63123387A (en) | 1986-11-13 | 1986-11-13 | Production of gamma-halo-beta-hydroxybutyric ester |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63123387A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0606899A3 (en) * | 1993-01-12 | 1995-07-05 | Daicel Chem | Processes for production of optically active 4-halo-3-hydroxybutyric acid esters. |
US6884607B2 (en) | 2000-12-07 | 2005-04-26 | Sumitomo Chemical Company, Limited | Process for producing optically active 4-halo-3-hydroxybutanoate |
US7135318B2 (en) | 2002-07-02 | 2006-11-14 | Sumitomo Chemical Company, Limited | Modified reductase and its gene |
US7163814B2 (en) | 2002-07-03 | 2007-01-16 | Sumitomo Chemical Company, Limited | Modified reductase and its gene, and use thereof |
CN110093302A (en) * | 2019-06-13 | 2019-08-06 | 浙江华睿生物技术有限公司 | A kind of lactobacillus mutant strain and its application |
-
1986
- 1986-11-13 JP JP26867886A patent/JPS63123387A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0606899A3 (en) * | 1993-01-12 | 1995-07-05 | Daicel Chem | Processes for production of optically active 4-halo-3-hydroxybutyric acid esters. |
US5559030A (en) * | 1993-01-12 | 1996-09-24 | Daicel Chemical Industries, Ltd. | Processes for production of optically active 4-halo-3-hydroxybutyric acid esters |
US6884607B2 (en) | 2000-12-07 | 2005-04-26 | Sumitomo Chemical Company, Limited | Process for producing optically active 4-halo-3-hydroxybutanoate |
US7135318B2 (en) | 2002-07-02 | 2006-11-14 | Sumitomo Chemical Company, Limited | Modified reductase and its gene |
US7163814B2 (en) | 2002-07-03 | 2007-01-16 | Sumitomo Chemical Company, Limited | Modified reductase and its gene, and use thereof |
CN110093302A (en) * | 2019-06-13 | 2019-08-06 | 浙江华睿生物技术有限公司 | A kind of lactobacillus mutant strain and its application |
CN110093302B (en) * | 2019-06-13 | 2020-08-28 | 浙江华睿生物技术有限公司 | Lactobacillus mutant strain and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS63112965A (en) | Production of yeast extract | |
NO151899B (en) | PROCEDURE FOR THE PREPARATION OF D-AMINO ACIDS BY MICROBIOLOGICAL HYDROLYSIS OF RACEMIC MIXTURES OF THE N-CARBAMOYL DERIVATIVES OR THE SIMILAR HYDANTOINES | |
JPH07289284A (en) | Method for production optically active 4-hydroxy-2-ketoglutaric acid | |
JP2840722B2 (en) | Method for producing 4-halo-3-hydroxybutyronitrile | |
JPS6156086A (en) | Microbial preparation of alpha-hydroxyacid and its salt | |
JPS63123387A (en) | Production of gamma-halo-beta-hydroxybutyric ester | |
JP3014171B2 (en) | Method for producing 4-halo-3-hydroxybutyramide | |
US2978384A (en) | Method for the production of 1-glutamic acid | |
WO2005098014A1 (en) | Microbe method for producing valienamine and validamine | |
JPH1175885A (en) | Production of calcium 2-hydroxy-4-methylthiobutanoate | |
JPS6129953B2 (en) | ||
JPH0795957B2 (en) | Method for producing 2-keto-L-gulonic acid | |
JPH0463675B2 (en) | ||
JPH066061B2 (en) | Method for producing ε-polylysine and ε-polylysine-producing bacterium | |
DE69427232T2 (en) | METHOD FOR PRODUCING DISACCHARIDES AND SACCHARIDES | |
JPH022589B2 (en) | ||
CN114134057B (en) | Saccharomyces cerevisiae SWGCJM001 and culture method and application thereof | |
JP3085783B2 (en) | Process for producing optically active 2-phenylpropionic acid and 2-phenylpropionamide | |
JPH01108988A (en) | Production of pyroracemic acid | |
JPH1042886A (en) | Production of beta-alanine by microorganism | |
JPS6319158B2 (en) | ||
JP3020266B2 (en) | Method for producing fosfomycin | |
JPS61173789A (en) | Production of 4-chloro-3-hydroxybutyric acid | |
JPS5911188A (en) | Preparation of d-glucosaminic acid | |
JP2899071B2 (en) | Method for producing L-α-alanine |